IMMX Company Profile and Key Details

Q: Who are the executives of IMMX?

Dr. Graham Ross FFPM, M.D.Chief Medical Officer & Head of Clinical Devel.Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.Co-Founder, Chief Executive Officer & ChairmanMr. Gabriel Morris B.A.Chief Financial Officer & DirectorMr. Sean Senn J.D., M.B.A., M.Sc., MBA, MScCo-FounderDr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.Scientific Co-FounderMr. Ben H. Lyon J.D.Executive Vice President & Gen. CounselMr. Nandan Oza B.S.Head of Chemistry, Manufacturing & Control

NASDAQ : IMMX

Immix Biopharma

$12.14

-0.07-0.57%

At Close 4:00 PM

$12.71

+0.57+4.69%

After-Market 08:30 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Immix Biopharma, Inc. (IMMX) stock declined over -0.57%, trading at $12.14 on NASDAQ, down from the previous close of $12.21. The stock opened at $12.49, fluctuating between $11.81 and $12.63 in the recent session.

Stock Snapshot

12.21

Prev. Close

660.44M

Market Cap

11.81

Day Low

-13.34

P/E Ratio

-0.91

EPS (TTM)

-0.57

Cash Flow per Share

12.49

Open

54.4M

Number of Shares

12.63

Day High

67.26%

Free Float in %

0.82

Book Value

1.05M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 15, 2026	12.49	12.63	11.81	12.14	1.05M
Sep 14, 2026	12.44	12.59	11.98	12.21	1.08M
Sep 11, 2026	12.86	13.29	12.02	12.14	1.19M
Sep 10, 2026	12.08	12.77	11.91	12.70	1.66M
Sep 09, 2026	13.12	13.23	12.24	12.31	1.29M
Sep 08, 2026	13.70	13.89	12.75	13.25	1.42M
Sep 04, 2026	13.68	14.09	13.60	13.91	1.05M
Sep 03, 2026	14.14	14.14	13.52	13.83	987.19K
Sep 02, 2026	14.00	14.23	13.42	13.96	1.58M
Sep 01, 2026	13.86	14.26	13.62	14.01	1.28M
Aug 31, 2026	13.70	14.15	13.52	14.03	1.33M
Aug 28, 2026	14.06	14.17	13.76	13.94	1.14M
Aug 27, 2026	14.03	14.61	13.77	14.31	1.51M
Aug 26, 2026	14.45	14.55	13.80	14.07	1.38M
Aug 25, 2026	13.60	15.10	13.49	14.47	3.65M
Aug 24, 2026	13.66	13.80	12.90	13.61	1.41M
Aug 21, 2026	13.36	13.76	13.12	13.66	1.51M
Aug 20, 2026	12.98	13.20	12.69	13.16	1.67M
Aug 19, 2026	11.99	13.19	11.99	13.19	1.97M
Aug 18, 2026	11.12	11.86	11.06	11.81	1.35M

Contact Details

Los Angeles, CA 90064

United States

https://www.immixbio.com 310 651 8041

About Company

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They are also developing IMX-111, a targeted biologic agent for colorectal cancers, and IMX-120, another tissue-specific biologic designed to address ulcerative colitis and severe Crohn's disease. In a strategic move, the company has forged a clinical collaboration and supply agreement with BeiGene Ltd. This partnership aims to conduct a Phase 1b combination clinical trial, evaluating IMX-110 in conjunction with BeiGene's anti-PD-1 drug, Tislelizumab, for solid tumor indications. Founded in 2012, Immix Biopharma maintains its headquarters in Los Angeles, California.

Stock Peers

ARGX

-10.78-1.09%

argenx SE$979.76 REGN

-19.63-2.47%

Regeneron Pharmaceuticals, Inc.$774.11 MDGL

-16.8-3.11%

Madrigal Pharmaceuticals, Inc.$523.26 VRTX

-4.88-0.94%

Vertex Pharmaceuticals Incorporated$514.63 UTHR

-2.35-0.47%

United Therapeutics Corporation$500.35 ONC

-7.33-2.07%

BeOne Medicines AG$346.50 KRYS

-3.35-0.99%

Krystal Biotech, Inc.$336.68 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-17.65-5.34%

Praxis Precision Medicines, Inc.$312.90 LGND

-3.67-1.31%

Ligand Pharmaceuticals Incorporated$276.98

Frequently Asked Questions

What is the current Immix Biopharma, Inc. (IMMX) stock price?

Immix Biopharma, Inc. (NASDAQ: IMMX) stock price is $12.14 in the last trading session. During the trading session, IMMX stock reached the peak price of $12.63 while $11.81 was the lowest point it dropped to. The percentage change in IMMX stock occurred in the recent session was -0.57% while the dollar amount for the price change in IMMX stock was - $0.07.

IMMX's industry and sector of operation?

The NASDAQ listed IMMX is part of Biotechnology industry that operates in the broader Healthcare sector. Immix Biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMMX?

Dr. Graham Ross FFPM, M.D.
Chief Medical Officer & Head of Clinical Devel.
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Co-Founder, Chief Executive Officer & Chairman
Mr. Gabriel Morris B.A.
Chief Financial Officer & Director
Mr. Sean Senn J.D., M.B.A., M.Sc., MBA, MSc
Co-Founder
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.
Scientific Co-Founder
Mr. Ben H. Lyon J.D.
Executive Vice President & Gen. Counsel
Mr. Nandan Oza B.S.
Head of Chemistry, Manufacturing & Control

How IMMX did perform over past 52-week?

IMMX's closing price is 525.77% higher than its 52-week low of $1.94 where as its distance from 52-week high of $15.10 is -19.6%.

How many employees does IMMX have?

Number of IMMX employees currently stands at 21.

Link for IMMX official website?

Official Website of IMMX is: https://www.immixbio.com

How do I contact IMMX?

IMMX could be contacted at phone 310 651 8041 and can also be accessed through its website. IMMX operates from 11400 West Olympic Boulevard, Los Angeles, CA 90064, United States.

How many shares of IMMX are traded daily?

IMMX stock volume for the day was 1.05M shares. The average number of IMMX shares traded daily for last 3 months was 1.84M.

What is the market cap of IMMX currently?

The market value of IMMX currently stands at $660.44M with its latest stock price at $12.14 and 54.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	21
Beta	0.11
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	21
Beta	0.11
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

IMMX Company Profile and Key Details

Immix Biopharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Technical Performance

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook